Salt-Sensitivity and Immunity Cell Activation
clinical trial
Press Enter · cited answer in seconds
0 sources
Salt-Sensitivity and Immunity Cell Activation
Summary
Salt-Sensitivity and Immunity Cell Activation is a clinical trial[1].
Key Facts
- Salt-Sensitivity and Immunity Cell Activation is in the country of United States[2].
- Salt-Sensitivity and Immunity Cell Activation's instance of is recorded as clinical trial[3].
- Salt-Sensitivity and Immunity Cell Activation's start time is recorded as +2020-03-31T00:00:00Z[4].
- Salt-Sensitivity and Immunity Cell Activation's end time is recorded as +2020-03-01T00:00:00Z[5].
- Salt-Sensitivity and Immunity Cell Activation's sponsor is recorded as Vanderbilt University Medical Center[6].
- Salt-Sensitivity and Immunity Cell Activation's main subject is recorded as inflammation[7].
- Salt-Sensitivity and Immunity Cell Activation's main subject is recorded as arterial hypertension[8].
- Salt-Sensitivity and Immunity Cell Activation's number of participants is recorded as {'unit': '1', 'amount': '+20'}[9].
- Salt-Sensitivity and Immunity Cell Activation's title is recorded as Salt-Sensitivity and Immunity Cell Activation[10].
- Salt-Sensitivity and Immunity Cell Activation's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
- Salt-Sensitivity and Immunity Cell Activation's ClinicalTrials.gov ID is recorded as NCT03753204[12].
- Salt-Sensitivity and Immunity Cell Activation's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+60'}[13].
- Salt-Sensitivity and Immunity Cell Activation's research intervention is recorded as furosemide sodium[14].
- Salt-Sensitivity and Immunity Cell Activation's clinical trial phase is recorded as phase I clinical trial[15].
- Salt-Sensitivity and Immunity Cell Activation's clinical trial phase is recorded as phase II clinical trial[16].
- Salt-Sensitivity and Immunity Cell Activation's research site is recorded as Vanderbilt University Medical Center[17].
- Salt-Sensitivity and Immunity Cell Activation's principal investigator is recorded as Annet Kirabo[18].
- Salt-Sensitivity and Immunity Cell Activation's study type is recorded as interventional study[19].